FAM
COGT icon

Fred Alger Management’s Cogent Biosciences COGT Stock Holding History

Fred Alger Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.7M Buy
1,239,700
+137,519
+12% +$5.08M 0.21% 60
2025
Q4 		$39.1M Buy
+1,102,181
New +$31M 0.15% 75
2022
Q4 		– Sell
-31,409
Closed -$469K – 525
2022
Q3 		$469K Buy
+31,409
New +$431K ﹤0.01% 399

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fred Alger Management's COGT Position: Q1 2026 in Review

Fred Alger Management increased its Cogent Biosciences (COGT) stake by 12% in Q1 2026, buying an estimated $5.08M and bringing the position to 1,239,700 shares worth $47.7M. The position accounts for 0.21% of the portfolio, ranked #60.

Fred Alger Management first reported a position in COGT in Q3 2022 and has held it in 3 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Fred Alger Management held 1,239,700 shares of Cogent Biosciences worth $47.7M as of Q1 2026.
  • Fred Alger Management bought 137,519 Cogent Biosciences shares in Q1 2026, an estimated $5.08M.
  • Cogent Biosciences made up 0.21% of Fred Alger Management's portfolio in Q1 2026, its #60 holding.
  • Fred Alger Management first reported a position in Cogent Biosciences in Q3 2022 and has held it in 3 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.